Novel non-narcotic analgesic for acute and chronic pain

Ended Project Grant Awarded Last action

Award ID
R42NS119103
Recipient
Awarding agency
Obligated
$5,294,687

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Funding
  • $4,454,260.00 Federal
  • $840,427.00 Non-federal
Place of performance
Louisiana, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $840,427 $0
Amendment $840,427 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $840,427 $0
Amendment $840,427 $0
Amendment $840,427 $840,427
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Original award $252,125 $0
Show all 12

Quick answers

Who received award R42NS119103?

R42NS119103 was awarded to South Rampart Pharma, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2020.

How much is award R42NS119103 worth?

$5,294,687 has been obligated on R42NS119103: $4,454,260 in federal funding and $840,427 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award